208 related articles for article (PubMed ID: 23088656)
1. Gene expression anti-profiles as a basis for accurate universal cancer signatures.
Bravo HC; Pihur V; McCall M; Irizarry RA; Leek JT
BMC Bioinformatics; 2012 Oct; 13():272. PubMed ID: 23088656
[TBL] [Abstract][Full Text] [Related]
2. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
3. A novel data mining method to identify assay-specific signatures in functional genomic studies.
Rollins DK; Zhai D; Joe AL; Guidarelli JW; Murarka A; Gonzalez R
BMC Bioinformatics; 2006 Aug; 7():377. PubMed ID: 16907975
[TBL] [Abstract][Full Text] [Related]
4. Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.
Tang ZQ; Han LY; Lin HH; Cui J; Jia J; Low BC; Li BW; Chen YZ
Cancer Res; 2007 Oct; 67(20):9996-10003. PubMed ID: 17942933
[TBL] [Abstract][Full Text] [Related]
5. Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue.
Drew JE; Mayer CD; Farquharson AJ; Young P; Barrera LN
J Mol Diagn; 2011 Mar; 13(2):233-42. PubMed ID: 21354059
[TBL] [Abstract][Full Text] [Related]
6. Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles.
Türeci O; Ding J; Hilton H; Bian H; Ohkawa H; Braxenthaler M; Seitz G; Raddrizzani L; Friess H; Buchler M; Sahin U; Hammer J
FASEB J; 2003 Mar; 17(3):376-85. PubMed ID: 12631577
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
8. Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
Cannon E; Buechler S
Clin Colorectal Cancer; 2019 Jun; 18(2):149-158. PubMed ID: 30853326
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
[TBL] [Abstract][Full Text] [Related]
10. Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.
Tebbit CL; Zhai J; Untch BR; Ellis MJ; Dressman HK; Bentley RC; Baker JA; Marcom PK; Nevins JR; Marks JR; Olson JA
Breast Cancer Res Treat; 2009 Dec; 118(3):635-43. PubMed ID: 19224362
[TBL] [Abstract][Full Text] [Related]
11. Gene Expression Signatures Based on Variability can Robustly Predict Tumor Progression and Prognosis.
Dinalankara W; Bravo HC
Cancer Inform; 2015; 14():71-81. PubMed ID: 26078586
[TBL] [Abstract][Full Text] [Related]
12. Rank-in: enabling integrative analysis across microarray and RNA-seq for cancer.
Tang K; Ji X; Zhou M; Deng Z; Huang Y; Zheng G; Cao Z
Nucleic Acids Res; 2021 Sep; 49(17):e99. PubMed ID: 34214174
[TBL] [Abstract][Full Text] [Related]
13. A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.
Mettu RK; Wan YW; Habermann JK; Ried T; Guo NL
Int J Biol Markers; 2010; 25(4):219-28. PubMed ID: 21161944
[TBL] [Abstract][Full Text] [Related]
14. Quality Control Usage in High-Density Microarrays Reveals Differential Gene Expression Profiles in Ovarian Cancer.
Villegas-Ruiz V; Moreno J; Jacome-Lopez K; Zentella-Dehesa A; Juarez-Mendez S
Asian Pac J Cancer Prev; 2016; 17(5):2519-25. PubMed ID: 27268623
[TBL] [Abstract][Full Text] [Related]
15. Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.
Vychytilova-Faltejskova P; Radova L; Sachlova M; Kosarova Z; Slaba K; Fabian P; Grolich T; Prochazka V; Kala Z; Svoboda M; Kiss I; Vyzula R; Slaby O
Carcinogenesis; 2016 Oct; 37(10):941-950. PubMed ID: 27485599
[TBL] [Abstract][Full Text] [Related]
16. miRNA as markers for the diagnostic screening of colon cancer.
Ahmed FE
Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
[TBL] [Abstract][Full Text] [Related]
17. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer.
Han Y; Huang H; Xiao Z; Zhang W; Cao Y; Qu L; Shou C
PLoS One; 2012; 7(12):e52745. PubMed ID: 23300757
[TBL] [Abstract][Full Text] [Related]
19. Classification between normal and tumor tissues based on the pair-wise gene expression ratio.
Yap Y; Zhang X; Ling MT; Wang X; Wong YC; Danchin A
BMC Cancer; 2004 Oct; 4():72. PubMed ID: 15469618
[TBL] [Abstract][Full Text] [Related]
20. Selection of relevant genes in cancer diagnosis based on their prediction accuracy.
Maglietta R; D'Addabbo A; Piepoli A; Perri F; Liuni S; Pesole G; Ancona N
Artif Intell Med; 2007 May; 40(1):29-44. PubMed ID: 16920342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
